PAK1 and breast carcinoma: To determine if these results were specific to MDA-MB-231 cells, we generated PAK1 knockdowns in the brain-metastatic cell line MDA-MB-231BR and the metastatic HER2 positive breast cancer cell line 21MT-1 (Supplemental Fig. 2A and B).